408 related articles for article (PubMed ID: 15730415)
1. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
3. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
Véliz J; Pineda G; Arancibia P; Wohllk N
Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of solitary toxic thyroid nodule with 131I: results in 43 patients].
Marín JF; Maraña G; Salto L; Astigarraga B; Estrada FJ; Lucas T; Barceló B
Med Clin (Barc); 1991 May; 96(19):730-2. PubMed ID: 1875750
[TBL] [Abstract][Full Text] [Related]
7. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
Vijayakumar V; Ali S; Nishino T; Nusynowitz M
Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
[TBL] [Abstract][Full Text] [Related]
8. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of solitary autonomous thyroid nodules treated with 131I.
Goldstein R; Hart IR
N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
[TBL] [Abstract][Full Text] [Related]
10. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule].
Gołkowski F; Jabrocka-Hybel A; Huszno B
Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hyperfunctioning thyroid nodules with percutaneous ethanol injection: Eight years' experience.
Monzani F; Caraccio N; Goletti O; Casolaro A; Lippolis PV; Cavina E; Miccoli P
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S54-8. PubMed ID: 9867198
[TBL] [Abstract][Full Text] [Related]
12. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
[TBL] [Abstract][Full Text] [Related]
13. The relationship between 24 h/4 h radioiodine-131 uptake ratio and outcome after radioiodine therapy in 1402 patients with solitary autonomously functioning thyroid nodules.
Filesi M; Travascio L; Montesano T; Di Nicola AD; Colandrea M; Ugolini F; Bruno R; Gross MD; Vestri A; Rubello D; Ronga G
Ann Nucl Med; 2009 May; 23(3):229-34. PubMed ID: 19322512
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
16. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975.
Holm LE
J Nucl Med; 1982 Feb; 23(2):108-12. PubMed ID: 7057249
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of thyroid scintigraphies after 131I therapy of solitary autonomous thyroid nodules.
Nygaard B; Jarløv AE; Hegedüs L; Schaadt B; Kristensen LO; Hansen JM
Thyroid; 1994; 4(2):167-71. PubMed ID: 7522683
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism.
Holm LE; Lundell G; Israelsson A; Dahlqvist I
J Nucl Med; 1982 Feb; 23(2):103-7. PubMed ID: 7057248
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
20. Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules.
Nygaard B
Thyroid; 1998 Mar; 8(3):223-7. PubMed ID: 9545108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
